Authors
Renad Saigh, Nader Kameli, Hassan A Hamali, Abdullah A Mobarki, Khaled Essawi, Waleed Hakami, Yara Alyahyawi, Aymen M Madkhali, Fahd Alaajam, Mohammed H Nahari, Abdulrahim R Hakami, Gasim Dobie
Published in
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. Volume 32. Pages 10760296261508904. Epub Nov 12, 2026.
Abstract
BackgroundEndothelial dysfunction and platelet activation contribute to the hypercoagulable state observed in severe COVID-19. This study investigated circulating P-selectin and von Willebrand factor (vWF) in ICU-admitted COVID-19 patients and examined their associations with hematological, coagulation, and in-hospital outcomes.Materials and methodsA case-control study was conducted involving 140 participants, including 70 ICU-admitted COVID-19 patients and 70 healthy controls. Complete blood counts (CBC), CBC-derived parameters, coagulation profiles, D-dimer levels, and soluble plasma concentrations of P-selectin and von Willebrand factor (vWF) were measured and correlated with hematological indices in the current study.ResultsCOVID-19 patients had significantly prolonged prothrombin time and activated partial thromboplastin time compared with controls (both p < 0.0001). Plasma P-selectin concentrations were significantly higher in COVID-19 patients than in controls (median 5674.50 [IQR 4778.50-6398.50] vs 3243.50 [2210.50-4332.75] pg/mL, p < 0.0001), whereas vWF concentrations did not differ significantly between groups (p = 0.1175). After adjustment for age and sex, COVID-19 status remained independently associated with higher P-selectin concentrations (adjusted ratio 1.620, 95% CI 1.319-1.989, p < 0.0001), whereas the association with vWF remained non-significant (adjusted ratio 1.533, 95% CI 0.896-2.624, p = 0.1179). Neither P-selectin nor vWF was independently associated with in-hospital mortality among COVID-19 patients with definitive outcomes.ConclusionICU-admitted COVID-19 patients exhibited marked elevation of circulating P-selectin that remained significant after adjustment for age and sex, supporting an association between severe COVID-19 and platelet/endothelial activation. In contrast, vWF did not differ significantly between groups after either unadjusted or adjusted analysis. Neither biomarker independently predicted in-hospital mortality in this cohort. These findings support P-selectin as a marker of vascular and platelet activation in severe COVID-19 while highlighting the need for larger, clinically well-characterized cohorts to determine its prognostic utility.
PMID:
43020137
Bibliographic data and abstract were imported from PubMed on 13 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 13
- Comments 0